Neauvia Organic Intense Lips (1 × 1 mL) is a hyaluronic acid dermal filler specifically formulated for lip enhancement, hydration, and contour definition.
It is designed to provide soft, natural-looking volume while maintaining lip flexibility and smooth movement, making it suitable for both augmentation and reshaping.
The formulation is optimized for superficial to mid-dermal placement, allowing precise control and even distribution within the delicate lip tissue.
Results typically last up to 6–9 months, depending on injection technique, lip dynamics, and individual metabolism.
Rheological properties / Product data
HA concentration: 24 mg/ml
Cross-linking agent: PEG-based technology
Elasticity (G’): Medium
Cohesivity: Medium
Texture: Soft, elastic HA gel
Lidocaine content: None
Packaging: 1 syringe × 1 ml
The PEG cross-linking technology supports biocompatibility and smooth tissue integration, helping achieve natural lip aesthetics.
Injection depth & tools
Recommended depth: Superficial to mid-dermis (lip mucosa)
Injection techniques: Linear threading, micro-bolus
Recommended instruments: Fine-gauge needle or cannula
Inject slowly with careful attention to lip anatomy to minimize swelling and achieve balanced contouring.
Storage & handling
Store at room temperature (do not freeze)
Protect from direct sunlight
Single-use only — use immediately after opening
Do not use if packaging is damaged or expired
Dispose of syringes and needles according to medical waste regulations
For use by licensed medical professionals only. Not intended for self-injection.
Precise micro‑aliquots in appropriate planes for lip augmentation; avoid intravascular injection; conservative dosing.
Common: redness, swelling, bruising, tenderness. Rare but serious: vascular occlusion (blanching, severe pain, visual changes—urgent care required).
Cross‑linked HA restores volume and contour; integrates with surrounding tissue.
Avoid alcohol 24h before and after treatment—vasodilation increases bleeding/bruising and may slow recovery.
Not recommended in pregnancy—elective injectables lack robust safety data; defer until after delivery.
Not advised during breastfeeding—limited data on transfer via milk and infant safety; postpone elective procedures.
